Characterization and response to exercise training of HDL-specific phospholipid efflux
The HDL-specific phospholipid efflux (HDL-SPE) assay is a novel cell-free measure of HDL function that is inversely associated with coronary artery disease. However, the effect of exercise training on HDL-SPE is unknown. The purpose of this study was to examine the effect of exercise training on HDL-SPE in a large, diverse cohort free of overt disease. Clinical and functional measures of HDL were taken before and after 20 weeks of endurance exercise training in 508 participants from the HERITAGE Family Study. Associations of HDL-SPE with HDL-related traits were examined using Pearson's correlations at baseline and following exercise training (significance: P < 7.4 × 10<sup>-4</sup>). The effect of exercise training on HDL-SPE was examined using paired t-tests (significance: P < 0.05). Mean (SD) HDL-SPE was 1.40 (0.19) and higher in females compared with males and in White participants compared with Black participants. Baseline HDL-SPE was strongly associated with HDL-C (r = 0.45) and apoA-I (r = 0.43, both P < 6.9 × 10<sup>-24</sup>) but not with measures of cholesterol efflux. Mean HDL-SPE increased (0.023, P = 0.002) following exercise training, but these increases only occurred in those with the lowest baseline HDL-SPE levels. Change in HDL-SPE was associated with changes in HDL-C (r = 0.27), medium HDL concentration (r = 0.24), and apoA-I and HDL size (r = 0.17, all P < 1.3 ×10<sup>-4</sup>). HDL-SPE increased following regular exercise, and changes in HDL-SPE were related to changes in HDL size and subclass concentrations. Our findings demonstrate that individuals at higher risk for coronary artery disease may experience the largest benefits from exercise training as related to this novel biomarker of HDL function.
Authors
- Edward B. Neufeld (ORCID: https://orcid.org/0000-0002-1248-6613)
- Eric C. Leszczynski (ORCID: https://orcid.org/0000-0002-1527-7374)
- Masaki Satō (ORCID: https://orcid.org/0000-0003-1277-7645)
- Anand K. Rohatgi (ORCID: https://orcid.org/0000-0003-0164-2382)
- Rafael Zubirán
- Claude Bouchard
- Sujoy Ghosh
- Prasun K. Dev
- Timothy John Collier
- Alan T. Remaley
- Mark A. Sarzynski
- Kiani J.C. Jacobs
- Charles S. Schwartz
- Robert J. Konrad
- Jeremy M. Robbins
- Robert E. Gerszten
Institutions
- Pennington Biomedical Research Center (US)
- Beth Israel Deaconess Medical Center (US)
- Cleveland Clinic (US)
- Jichi Medical University (JP)
- University of South Carolina (US)
- Eli Lilly (United States) (US)
- National Heart, Lung, and Blood Institute (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Journal of Lipid Research
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1016/j.jlr.2026.100993
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Institute of Nursing Research
- National Institute of General Medical Sciences